Publikationen 2012 - 2019

2019 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2019): Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid-induced hyperglycemia in patients with acute graft-versus-host disease: A randomized trial. J Diabetes Investig. 2019; 10(2):339-342
(2019): High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML. Cancer Med. 2019; 8(4):1771-1778
(2019): CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia. Int J Mol Sci. 2019; 20(23):
(2019): Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD. BLOOD ADV. 2019; 3(14): 2218-2229.
(2019): National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution. FRONT IMMUNOL. 2019; 10: 1879-1879.
(2019): The &lti>CXCR4-CXCL12&lt/i>-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro. Int J Mol Sci. 2019; 20(19):
(2019): Clinical implications of subclonal &lti>TP53&lt/i> mutations in acute myeloid leukemia. Haematologica. 2019; 104(3):516-523
(2019): Using Interleukin 6 and 8 in Blood and Bronchoalveolar Lavage Fluid to Predict Survival in Hematological Malignancy Patients With Suspected Pulmonary Mold Infection. Front Immunol. 2019; 10(10):1798-1798
(2019): Epidemiology and Treatment of Patients with Haemophilia in Austria-Update from the Austrian Haemophilia Registry. Hamostaseologie. 2019; 39(3):284-293
(2019): Whole-Body Lung Function Test-Derived Outcome Predictors in Allogenic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2019; 25(1):129-136
(2019): Influencing factors on career choice and current occupation analysis of adult survivors of childhood cancer: a special focus on health-related occupations. Magazine of European medical oncology. 2019; 12: 83-90.
(2019): Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland. BIOL BLOOD MARROW TR. 2019; 25(7): 1450-1455.
Kurzbericht/Letter
(2019): Imatinib stimulates prostaglandin E&ltsub>2&lt/sub> and attenuates cytokine release via EP4 receptor activation. J Allergy Clin Immunol. 2019; 143(2):794-797
(2019): Detection of AML-specific TP53 mutations in bone marrow-derived mesenchymal stromal cells cultured under hypoxia conditions. Ann Hematol. 2019;
Übersichtsarbeiten
(2019): "Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries". BONE MARROW TRANSPL. 2019; 54(8): 1179-1188.
(2019): RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis. Int J Mol Sci. 2019; 20(22):
Fallberichte
(2019): A wearable cardioverter defibrillator for prevention of sudden cardiac death in a hematologic patient-a case report MEMO-MAG EUR MED ONC. 2019; 12(3): 269-271.
Korrekturen
(2019): Correction to: Ruxolitinib therapy formyelofibrosis in Austria : Consensus on therapy management. WIEN KLIN WOCHENSCHR. 2019; 131(1-2): 47-47.

2019 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2019): POSTTRANSPLANT OUTCOMES IN ALLOGENEIC AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN AUSTRIA IN COMPARISON TO THE EBMT BENCHMARK: A RETROSPECTIVE ANALYSIS OF THE AUSTRIAN SCT REGISTRY (ASCTR) 2000-2017 TRANSPL INT. 2019; 32: 20-20.
(2019): Nr4a1-loss causes an acceleration of Myc-driven lymphomagenesis and an induction of gene of the B7-CD28 BRIT J CANCER. 2019; 121: 8-8.-Cancer Conference of the National-Cancer-Research-Institute (NCRI); NOV 03-05, 2019; Glasgow, SCOTLAND.
(2019): Myeloablative conditioning may contribute to disease control after stem cell transplantation in blastic plasmacytoid dentric cell neoplasia BONE MARROW TRANSPL. 2019; 54: 108-109.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY.
(2019): Dysregulated eukaryotic initiation factors may impact on the pathogenesis of primary central nervous system lymphomas ONCOL RES TREAT. 2019; 42: 82-82.
(2019): Ambiguities in data reporting - multiple answer option for causes of death as hinderance for data analysis BONE MARROW TRANSPL. 2019; 54: 676-677.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY.
(2019): Treatment of high risk aggressive B cell lymphomas with DA EPOCH R - a retrospective analysis ONCOL RES TREAT. 2019; 42: 82-82.
(2019): Nr4a1 is implicated in the regulation of immune checkpoints in aggressive lymphomas ONCOL RES TREAT. 2019; 42: 135-135.
(2019): Association of uric acid levels before start of conditioning with mortality after alloSCT - a prospective, non-interventional study of the EBMT transplant complication working party BONE MARROW TRANSPL. 2019; 54: 296-297.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY.
(2019): Association of serum ferritin levels before start of conditioning with mortality after alloSCT - a prospective, non-interventional study of the EBMT transplant complication working party BONE MARROW TRANSPL. 2019; 54: 238-239.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY.
(2019): Treatment of acute refractory gastrointestinal graft-versus-host-disease by fecal microbiota transplantation BONE MARROW TRANSPL. 2019; 54: 294-295.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY.
(2019): Differences of the chemokine receptor expression profile of aggressive lymphoma and GCB-cells and probable influence on clinical outcome ONCOL RES TREAT. 2019; 42: 83-83.
(2019): ALPINA: Real World Analysis of 1st line RVd treatment in Transplant Eligible & Transplant-non-Eligible MM patients with a focus on tolerability and efficacy CL LYMPH MYELOM LEUK. Abstract Book 17th International Myeloma Workshop. 2019; 19(10):E220-E220.-17th International Myeloma Workshop; SEP 12-15, 2019; Boston, USA.

2018 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2018): Co-culture of human fibroblasts and Borrelia burgdorferi enhances collagen and growth factor mRNA. Arch Dermatol Res. 2018; 310(2):117-126
(2018): Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study. BMC CANCER. 2018; 18(1): 1008-1008.
(2018): Phenotyping and Target Expression Profiling of CD34&ltsup>+&lt/sup>/CD38&ltsup>-&lt/sup> and CD34&ltsup>+&lt/sup>/CD38&ltsup>+&lt/sup> Stem- and Progenitor cells in Acute Lymphoblastic Leukemia. Neoplasia. 2018; 20(6):632-642
(2018): Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia. Eur J Haematol. 2018; 74(9):
(2018): Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration. Blood. 2018; 131(7): 826-830.
(2018): Synergistic Targeting of the Regulatory and Catalytic Subunits of PI3Kδ in Mature B-cell Malignancies. Clin Cancer Res. 2018; 24(5):1103-1113
(2018): Synthesis of Novel Shikonin Derivatives and Pharmacological Effects of Cyclopropylacetylshikonin on Melanoma Cells. Molecules. 2018; 23(11):
(2018): Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survival. Sci Rep. 2018; 8(1):14528-14528
(2018): Residual disease detection using targeted parallel sequencing predicts relapse in cytogenetically normal acute myeloid leukemia. Am J Hematol. 2018; 93(1):23-30
(2018): Downregulation of p53 drives autophagy during human trophoblast differentiation. Cell Mol Life Sci. 2018; 75(10):1839-1855
(2018): Acute myeloid leukemia with severe coagulation disorder and concomitant central nervous system bleeding - a clinical diagnostic case report. EJIFCC. 2018; 29(2): 146-151.
(2018): Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples. J Infect. 2018; 77(3):235-241
(2018): Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study. Mycoses. 2018; 61(3):201-205
(2018): Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia. Wien Klin Wochenschr. 2018; 130(3-4):115-125
(2018): Influence of silibinin and β-β-dimethylacrylshikonin on chordoma cells. Phytomedicine. 2018; 49(11):32-40
(2018): Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management. WIEN KLIN WOCHENSCHR. 2018; 130(17-18): 495-504.
(2018): Comparative Gene Expression Analysis in WM164 Melanoma Cells Revealed That &lti>β&lt/i>-&lti>β&lt/i>-Dimethylacrylshikonin Leads to ROS Generation, Loss of Mitochondrial Membrane Potential, and Autophagy Induction. Molecules. 2018; 23(11):
(2018): Antifungal Prophylaxis with Posaconazole Delayed-Release Tablet and Oral Suspension in a Real-Life Setting: Plasma Levels, Efficacy, and Tolerability. Antimicrob Agents Chemother. 2018; 62(6):
(2018): The influence of glucocorticoid receptor single nucleotide polymorphisms on outcome after haematopoietic stem cell transplantation. Int J Immunogenet. 2018; 13(8):
(2018): The frequency of occurrence of fish-shaped red blood cells in different haematologic disorders. Clin Chem Lab Med. 2018; 56(2):323-326
(2018): The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial. Haematologica. 2018; 103(10):1698-1707
(2018): Visceral leishmaniasis in a patient with diabetes mellitus type 2 and discrete bicytopenia. CLIN CASE REP. 2018; 6(1): 78-81.
(2018): Diagnosis, management and response criteria of iron overload in myelodysplastic syndromes (MDS): updated recommendations of the Austrian MDS platform. Expert Rev Hematol. 2018; 11(2):109-116
(2018): Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter? TRANSFUSION. 2018; 58(4): 1045-1053.
Kurzbericht/Letter
(2018): Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing. Leuk Lymphoma. 2018; 59(2):501-504
(2018): Immunohistochemical double hit score enhances NCCN-IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma. Br J Haematol. 2018; 183(1):142-146
(2018): Accuracy and usability of the eGVHD app in assessing the severity of graft-versus-host disease at the 2017 EBMT annual congress. Bone Marrow Transplant. 2018; 53(4):490-494
(2018): The TP53 Pro72Arg SNP in de novo acute myeloid leukaemia - results of two cohort studies involving 215 patients and 3759 controls. Br J Haematol. 2018; 181(1):148-151
(2018): Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome. Blood Cancer J. 2018; 8(9): 79-79.
Übersichtsarbeiten
(2018): Austrian recommendations for the management of polycythemia vera. Wien Klin Wochenschr. 2018; 130(17-18):535-542
(2018): Sport Therapy and Physiotherapy for Treatment of cGvHD PHYS MED REHAB KUROR. 2018; 28(4): 224-230.
Editorials
(2018): Editorial: Cellular Therapies: Past, Present and Future. Front Immunol. 2018; 9(5):1966-1966
Fallberichte
(2018): Tension Hydropneumothorax after Lung Biopsy. NOTFALL RETTUNGSMED. 2018; 21(8): 695-696.

2018 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2018): Overexpression of miR199a and miR497 regulates Nf-kappa B and B-cell receptor signalling in diffuse large B-cell lymphoma (DLBCL) ONCOL RES TREAT. 2018; 41: 81-82.
(2018): Starvation increases the anticancer activity of Ibrutinib in ABC-DLBCL cells in vitro ONCOL RES TREAT. 2018; 41: 81-81.-DGHO; Oktober 2018; wien.
(2018): ZUMA-7: RANDOMIZED PHASE 3 ESSAY OF AXICABTAGEN CILOLEUCEL (AXI-CEL) VS STANDARD TREATMENT (SOC) IN PATIENTS WITH LYMPHOMA B DIFFUSE OF LARGE CELLS IN RECYCLED/REFRACTORY (R/R DLBCL) HAEMATOLOGICA. 2018; 103: 359-359.-60th National Congress of the Spanish-Society-of-Hematology-and-Hemotherapy; OCT 11-13, 2018; Granada, SPAIN.
(2018): Loss of RKIP expression is a frequent event in chronic myelomonocytic leukemia and functionally involved in the pathogenesis of this malignancy ONCOL RES TREAT. 2018; 41: 27-27.
(2018): GPR56 and CLL-1 (CLEC12A) as putative leukemic stem cell markers in CD34-positive acute myeloid leukemia ONCOL RES TREAT. 2018; 41: 73-73.
(2018): Low NR4A1 expression is associated with an up-regulation of immune checkpoints and their ligands in DLBCL ONCOL RES TREAT. 2018; 41: 82-82.
(2018): Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favorable cancer specific survival ONCOL RES TREAT. 2018; 41: 82-83.
(2018): Nr4a1 has as a tumor suppressive function in Myc-driven lymphomagenesis by altering the tumor microenvironment ONCOL RES TREAT. 2018; 41: 82-82.-DHGO; Oktober 2018; Wien.
(2018): Incidence of Acute Graft-Versus-Host Disease and Survival after Allogeneic Hematopoietic Cell Transplantation over Time: A Study from the Transplant Complications and Chronic Malignancies Working Party of the EBMT BLOOD. 2018; 132:
(2018): Deregulation of the micro-RNA-23a/TOP2B axis causes resistance to cytarabine in acute myeloid leukemia ONCOL RES TREAT. 2018; 41: 243-243.
(2018): Invasive Aspergillosis: Performance of New and Established Diagnostic Approaches with Same-Day Blood and Bronchoalveolar Lavage - a Prospective Cohort Study MED MYCOL. 2018; 56: S34-S34.
(2018): Exercise therapy for treatment of chronic graft-versus-host disease: recommendations of the German-Austrian-Swiss GvHD consortium ONCOL RES TREAT. 2018; 41: 64-64.
(2018): A role of C/EBP alpha in early dendritic cell development ONCOL RES TREAT. 2018; 41: 102-102.
(2018): Treatment standards in aggressive lymphomas ONCOL RES TREAT. . 2018; 41: 22-22.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28-OCT 2, 2018; Vienna, AUSTRIA.
(2018): Impact of TP53 mutated subclones in acute myeloid leukemia Blood. 2018; 132(Suppl ):-Annual Meeting of the American Society of Hematology; December 1-4, 2018; San Diego.
(2018): Treatment of high risk aggressive B cell lymphomas with DA EPOCH R- the Austrian experience ONCOL RES TREAT. 2018; 41: 46-46.
(2018): Reduced NR4A1 levels are associated with high expression of miR-15a and miR-15a*in DLBCL ONCOL RES TREAT. 2018; 41: 81-81.
(2018): CLL: State of the Art Therapy, First-line therapy ONCOL RES TREAT. 2018; 41: 266-266.
(2018): A National Multi-Center Randomized Study to Assess the Accuracy, Reliability, and User Satisfaction of the Ebmt Gvhd App in Graft Versus Host Disease Assessment BIOL BLOOD MARROW TR. 2018; 24(3):S191-S191.-Blood and Marrow Transplantion Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT); FEB 21-25, 2018; Salt Lake City, UT.
(2018): Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma ONCOL RES TREAT. 2018; 41: 50-50.
(2018): TP53 mutated acute myeloid leukemia ONCOL RES TREAT. . 2018; 41: 257-257.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28-OCT 2, 2018; Vienna, AUSTRIA.
(2018): Role of TPO agonists in the chronic immune thrombocytopenia treatment algorithm - a single-center registry analysis ONCOL RES TREAT. 2018; 41: 105-106.
(2018): KIDSAP - HOME USE OF THE ARTIFICIAL PANCREAS IN VERY YOUNG CHILDREN WITH TYPE 1 DIABETES: THE PILOT STUDY DIABETES TECHNOL THE. 2018; 20: A37-A37.-78 ADA Meeting; Jun 22-24; Orlando.
(2018): Changes in immunosuppressive treatment of chronic graft-versus-host disease - comparison of 2 surveys within hematopoietic stem cell transplant centers in Germany, Austria and Switzerland performed in 2009 and 2018 ONCOL RES TREAT. 2018; 41: 119-119.
(2018): Management of side effects of tyrosine kinase inhibitors ONCOL RES TREAT. . 2018; 41: 229-229.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28-OCT 2, 2018; Vienna, AUSTRIA.

2017 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2017): Expression of Serum microRNAs is Altered During Acute Graft-versus-Host Disease. Front Immunol. 2017; 8(5):308-308
(2017): Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93(star) As Biomarkers for Acute Graft-wersus-Host Disease FRONT IMMUNOL. 2017; 8: 1446
(2017): Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis. Med Mycol. 2017; 55(5):528-534
(2017): Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT. Biol Blood Marrow Transplant. 2017; 23(1):44-52
(2017): Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis. MYCOSES. 2017; 60(12): 818-825.
(2017): Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease. Am J Hematol. 2017; 92(9):885-891
(2017): Red blood cell morphology in patients with beta-thalassemia minor LABORATORIUMSMEDIZIN. 2017; 41(1): 49-52.
(2017): Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis. Blood. 2017; 130(7): 946-948.
(2017): FLT3 and FLT3-ITD phosphorylate and inactivate the cyclin-dependent kinase inhibitor p27&ltsup>Kip1&lt/sup> in acute myeloid leukemia. Haematologica. 2017; 102(8):1378-1389
(2017): Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group. Int J Mol Sci. 2017; 18(2):
(2017): Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial. J Cancer Res Clin Oncol. 2017; 143(8):1613-1619
(2017): Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT. Bone Marrow Transplant. 2017; 52(2):209-215
(2017): The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis. Bone Marrow Transplant. 2017; 52(3):357-362
(2017): Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study. Br J Haematol. 2017; 178(1):61-71
(2017): Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement. Wien Klin Wochenschr. 2017; 129(9-10):293-302
(2017): Early Hyperglycemia after Initiation of Glucocorticoid Therapy Predicts Adverse Outcome in Patients with Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2017; 23(7):1186-1192
(2017): The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cells ONCOTARGET. 2017; 8(40): 67709-67722.
Kurzbericht/Letter
(2017): Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia. Diabetes Metab. 2017; 43(6):560-562
(2017): IDH Mutation, Competitive Inhibition of FTO, and RNA Methylation. Cancer Cell. 2017; 31(5): 619-620.
(2017): Evidence for a role of decitabine in the treatment of myeloid sarcoma. Ann Hematol. 2017; 96(3):505-506
(2017): Vaccination of allogeneic hematopoietic stem cell transplant recipients-what should be considered? Ann Hematol. 2017; 96(4): 701-702.
(2017): A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma. Blood. 2017; 129(3): 383-385.
(2017): Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data. Blood Cancer J. 2017; 7(12):643-643
(2017): The TP53 Pro72Arg SNP in de novo acute myeloid leukemia. Haematologica. 2017; 102(5): e214-e215-e214-e215.
(2017): Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-&lti>versus&lt/i>-host-disease. Haematologica. 2017; 102(5):e210-e213-e210-e213
Übersichtsarbeiten
(2017): Cost and quality issues in establishing hematopoietic cell transplant program in developing countries. Hematol Oncol Stem Cell Ther. 2017; 10(4):167-172
(2017): Function and Clinical Implications of Long Non-Coding RNAs in Melanoma. Int J Mol Sci. 2017; 18(4):
Fallberichte
(2017): The Case | Acute kidney injury and hemolysis in a 58-year-old woman. Kidney Int. 2017; 91(4): 993-994.
Kommentare
(2017): Response to Harrison et al. 'Clinically relevant differences between BCSH and WHO diagnostic criteria for ET'. Leukemia. 2017; 31(3):768-769
(2017): Chronic GVHD: progress in salvage treatment? Blood. 2017; 130(21):2237-2238

2017 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2017): Efficacy and safety of an insulin decision support system in the treatment of steroid hyperglycaemia in patients with graft-versus- host-disease: a randomised pilot trial. Diabetologia. 2017; 60(S1):S323-S324.-53rd Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 11-15, 2017; Lisbon, PORTUGAL.
(2017): Expression of serum MicroRNAs is dysregulated during acute graft versus host disease BONE MARROW TRANSPL. 2017; 52: S486-S486.
(2017): Celiac Screening in Children and Adolescents with Diabetes mellitus Type I - Is Genotyping of celiac-specific HLA-Markers used as a Screening Method? WIEN KLIN WOCHENSCHR. 2017; 129: 179-179.-45. Jahrestagung der Österreichischen Diabetesgesellschaft, 16.-18. November 2017; Salzburg ; Nov 16-18, 2017; Salzburg.
(2017): LOSS OF RAF KINASE INHIBITOR PROTEIN IS INVOLVED IN MYELOMONOCYTIC LINEAGE COMMITMENT AND AGGRAVATES THE DEVELOPMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN A MURINE IN-VIVO MODEL HAEMATOLOGICA. 2017; 102: 148-149.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN.
(2017): RAF KINASE INHIBITOR PROTEIN IS INVOLVED IN THE DEVELOPMENT OF MYELOID SARCOMA HAEMATOLOGICA. 2017; 102: 361-362.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN.
(2017): CXCR4 AND CXCL12 ARE IMPLICATED IN BONE MARROW INFILTRATION PROCESS OF AGGRESSIVE B CELL LYMPHOMAS AND THEIR INHIBITION SUPPRESSES LYMPHOMA CELL GROWTH IN VITRO. HAEMATOLOGICA. HAEMATOLOGICA102: 572-572. PAVIA: FERRATA STORTI FOUNDATION; ( Presented at: 22nd Congress of the European-Hematology-Association, Madrid, SPAIN, JUN 22-25, 2017)
(2017): LOSS OF NR4A1 ACCELERATES MYC-DRIVEN LYMPHOMAGENESIS ACCOMPANIED BY OVEREXPRESSION OF GENES INVOLVED IN IMMUNOREGULATION. HAEMATOLOGICA. 2017; 102: 560-561.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN.
(2017): Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment ONCOL RES TREAT. 2017; 40: 108-108.
(2017): Persistence of non-DNMT3A mutations predicts relapse in cytogenetically normal AML ONCOL RES TREAT. 2017; 40: 140-141.
(2017): High spontaneous in-vitro myeloid colony growth is an adverse risk factor in chronic myelomonocytic leukemia Oncol Res Treat. 2017; 40(S3):131-131.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 29 - OCT 3, 2017; Stuttgart, GERMANY. (ISBN: 978-3-318-06110-9 )
(2017): Triacetylfusarinine C for aspergillosis: from imaging to Urine analysis MYCOSES. 2017; 60: 34-34.-TIMM; OCT 6-9, 2017; Belgrade, SERBIA.
(2017): Levels of interleukin-6 and-8 in serum and bronchoalveolar lavage fluid are elevated in haematological malignancy patients with invasive pulmonary aspergillosis: A nested case control study MYCOSES. 2017; 60: 101-102.-TIMM; OCT 6-9, 2017; Belgrade, SERBIA.
(2017): Levels of interleukin-6 and-8 in bronchoalveolar lavage fluid are elevated in haematological patients with invasive pulmonary aspergillosis: A case control study. MYCOSES. . 2017; 60: 6-7.-51. wiss. Tagung der deutsschrachigen Mykologischen Gesellschaft; AUG 21 - SEPT 2, 2017; Münster.
(2017): The JETS-project of the German-Austrian-Swiss GVHD Consortium - a prospective study of late effects in adolescent and young adults after stem cell transplantation ONCOL RES TREAT. 2017; 40: 286-286.
(2017): Adolescent and young adults versus older adults in the setting of allogeneic stem cell transplantation - two cohorts with special needs ONCOL RES TREAT. 2017; 40: 230-231.
(2017): POST-RECANALIZATION TCD EXAMINATION MAY PREDICT SYMPTOMATIC INTRACEREBRAL BLEEDING IN PATIENTS WITH ISCHAEMIC STROKE INT J STROKE. 2017; 12: 23-23.
(2017): KidsAP - The artificial pancreas in children aged 1 to 7 years with type 1 diabetes WIEN KLIN WOCHENSCHR. 2017; 129: 162-162.-45. Jahrestagung der Österreichischen Diabetesgesellschaft; Nov 16-18; Salzburg.
(2017): Serum and extracellular vesicle MicroRNAs miR-423, miR-199 and miR-93*as biomarkers for acute graft-versus-host disease BONE MARROW TRANSPL. 2017; 52: S509-S509.
(2017): Successful treatment of steroid-refractory acute gastrointestinal graft-versus-host-disease by fecal microbiota transplantation BONE MARROW TRANSPL. 2017; 52: S232-S232.
(2017): CHROMOSOMAL ABERRATIONS IN THERAPY-RELATED MYELODYSPLASTIC SYNDROMES - RELATIONS TO PRIMARY DISEASE, THERAPY AND PROGNOSTIC SIGNIFICANCE LEUKEMIA RES. .. 2017; 55: S32-S33.-14th International Symposium on Myelodysplastic Syndromes (MDS); MAY 03-06, 2017; Valencia, SPAIN.
(2017): Treatment of high risk aggressive B cell lymphomas with DA EPOCH R - a retrospective analysis ONCOL RES TREAT. 2017; 40: 69-70.
(2017): R-EFECT: A multicenter, retrospective evaluation of CML therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting ONCOL RES TREAT. 2017; 40: 58-58.
(2017): Triacetylfusarinine C determination in urine samples from hematological malignancy patients: a potential new biomarker for invasive aspergillosis MYCOSES. 2017; 60: 35-35.-8th Trends in Medical Mycology; OCT 6-9, 2017; Belgrade, SERBIA.
(2017): Early hyperglycaemia after initiation of glucocorticoid therapy predicts adverse outcome in patients with acute graft-versus-host disease BONE MARROW TRANSPL. 2017; 52: S285-S285.
(2017): Translation initiation factors as novel prognostic biomarkers of aggressive B-cell lymphomas VIRCHOWS ARCH. 2017; 471: S43-S43.

2016 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2016): Infections in patients with acute myeloid leukemia treated with low-intensity therapeutic regimens: Risk factors and efficacy of antibiotic prophylaxis. Leuk Res. 2016; 42(3):47-51
(2016): Umbilical Cord Blood Transplantation Is a Feasible Rescue Therapeutic Option for Patients Suffering from Graft Failure after Previous Hematopoietic Stem Cell Transplantation. Oncology. 2016; 90(3):160-166
(2016): Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia. Eur J Haematol. 2016; 97(6):511-516
(2016): Pentraxin-3 levels in graft-versus-host disease during allogeneic hematopoietic stem cell transplantation. Exp Hematol. 2016; 44(10):917-923
(2016): Specificity of mannan antigen and anti-mannan antibody screening in patients with haematological malignancies at risk for fungal infection. Mycoses. 2016; 59(6):374-378
(2016): Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria. Leukemia. 2016; 30(5):1126-1132
(2016): Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. Bone Marrow Transplant. 2016; 51(6):778-785
(2016): Impact of genomic risk factors on survival after haematopoietic stem cell transplantation for patients with acute leukaemia. Int J Immunogenet. 2016; 43(6):404-412
(2016): Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications. J Hematol Oncol. 2016; 9(6):39-39
(2016): Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels. Antimicrob Agents Chemother. 2016; 60(9):5595-5599
(2016): Chemotherapy-Induced Intestinal Mucosal Barrier Damage: a Cause of Falsely Elevated Serum 1,3-Beta-d-Glucan Levels? J Clin Microbiol. 2016; 54(3):798-801
(2016): NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients. Br J Cancer. 2016; 115(10):1264-1272
(2016): Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis. J Cancer Res Clin Oncol. 2016; 142(6):1307-1314
(2016): Prognostic potential of 1,3-beta-d-glucan levels in bronchoalveolar lavage fluid samples. J Infect. 2016; 72(1):29-35
(2016): Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation. Transpl Infect Dis. 2016; 18(3):466-470
(2016): Urine Galactomannan-to-Creatinine Ratio for Detection of Invasive Aspergillosis in Patients with Hematological Malignancies. J Clin Microbiol. 2016; 54(3):771-774
(2016): Venous thromboembolism in a patient with persistent inhibitor to coagulation factor V - a case report. Clin Chem Lab Med. 2016; 54(9):e269-e271
(2016): Adiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation. Croat Med J. 2016; 57(3):255-265
(2016): Development, preliminary usability and accuracy testing of the EBMT 'eGVHD App' to support GvHD assessment according to NIH criteria-a proof of concept. Bone Marrow Transplant. 2016; 51(8):1062-1065
(2016): Kidney Transplantation With Corticosteroids Alone After Haploidentical HSCT From The Same Donor. Transplantation. 2016; 100(10):2219-2221
(2016): Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation. J Clin Oncol. 2016; 34(19):2212-2220
(2016): Autologous cell sources in therapeutic vasculogenesis: In vitro and in vivo comparison of endothelial colony-forming cells from peripheral blood and endothelial cells isolated from adipose tissue. CYTOTHERAPY. 2016; 18(2): 242-252.
(2016): The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma. J Clin Pathol. 2016; 69(4):326-330
(2016): Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice. Atherosclerosis. 2016; 244(3):9-21
(2016): Higher incidence of the SNP Met 788 Ile in the coding region of A20 in diffuse large B cell lymphomas. Tumour Biol. 2016; 37(4):4785-4789
(2016): Extracorporeal Photopheresis TRANSFUSIONSMEDIZIN. 2016; 6(3): 115-122.
(2016): Acute myeloid leukemia with TP53 germ line mutations. Blood. 2016; 128(18): 2270-2272.
Kurzbericht/Letter
(2016): Pulmonary arterial pressure in patients with myelodysplastic syndromes. Leuk Lymphoma. 2016; 57(11):2723-2726
Übersichtsarbeiten
(2016): Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association. Biol Blood Marrow Transplant. 2016; 22(1):96-103
(2016): Anemia management in cancer patients with chronic kidney disease. Eur J Intern Med. 2016; 36(4):13-19
(2016): Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments. Front Immunol. 2016; 7(1):470-470
(2016): B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol. 2016; 7(3):660-660
(2016): Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol. 2016; 7(50):507-507
(2016): Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs. Int J Mol Sci. 2016; 17(12):
Editorials
(2016): Chronic graft-vs-host disease in 2016: a major challenge and an opportunity. CROAT MED J. 2016; 57(1): 1-3.
Kommentare
(2016): Correspondence: Reply to 'SEMA4A variation and risk of colorectal cancer'. Nat Commun. 2016; 7:10695-10695

2016 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2016): Pilot Study for Verifying the Feasibility and Efficiency of a standard Blood Glucose Control using an automated Decision Support Algorithm in the Insulin Therapy of Patients with Graft-versus-host Disease WIEN KLIN WOCHENSCHR. 2016; 128: S407-S407.-44. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 17-19, 2016; Salzburg, AUSTRIA.
(2016): Involvement of vascular aldosterone synthase in phosphate- induced osteo-/chondrogenic signaling and calcification of vascular smooth muscle cells ACTA PHYSIOL. 2016; 216:
(2016): NR4A3 Suppresses Lymphomagenesis In Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1. BLOOD. BLOOD128: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 03-06, 2016)
(2016): Persitence of non-DNMT3A mutations predicts relapse in cytogenetically normal AML. Oncol Res Treat 2016. 2016; 39(suppl3):140--Jahrestagung DGHO; OCT 14-18,2016; Leipzig. (ISBN: 2296-5270 )
(2016): Allogeneic Stem Cell Transplantation for MDS Patients More Than 70 Years of Age: Update of a Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT BONE MARROW TRANSPL. 2016; 51: S510-S511.-42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; APR 03-06, 2016; Valencia, SPAIN.
(2016): The JETS-project of the German-Austrian-Swiss GVHD Consortium - a prospective study of late effects in adolescent and young adults after stem cell transplantation ONCOL RES TREAT. 2016; 39: 286-286.
(2016): Adolescent and young adults versus older adults in the setting of allogeneic stem cell transplantation - two cohorts with special needs ONCOL RES TREAT. 2016; 39: 230-231.
(2016): Linking MED-A-data to an external database: the GVHD-registry project BONE MARROW TRANSPL. 2016; 51: S549-S550.-42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; APR 03-06, 2016; Valencia, SPAIN.
(2016): Thrombozytenrefraktärität durch Anti-HPA 3a bei Zustand nach allogener Blutstammzelltransplantation: ein Fallbericht. TRANSPL INT. . 2016; 29(s4):21-21.-Austrostransplant 2016; OCT 19-21, 2016; Schladming, AUSTRIA.
(2016): Conventional post-remission therapy in adult acute myeloid leukemia - a systematic review/meta-analysis WIEN KLIN WOCHENSCHR. 2016; 128: S385-S385.
(2016): IMPAIRED BASE EXCISION REPAIR GLYCOSYLASE/AP ENDONUCLEASE ACTIVITY CONTRIBUTES TO CYTARABINE RESISTANCE IN ACUTE MYELOID LEUKEMIA HAEMATOLOGICA. 2016; 101: 211-212.
(2016): TREATMENT OF HIGH RISK AGGRESSIVE B CELL LYMPHOMAS WITH DA EPOCH R- A RETROSPECTIVE ANALYSIS HAEMATOLOGICA. 2016; 101: 698-698.-21st Congress of the European-Hematology-Association; JUN 09-12, 2016; Copenhagen, DENMARK.
(2016): R-EFECT: A multicenter, retrospective evaluation of CML therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting ONCOL RES TREAT. .. 2016; 39: 58-58.
(2016): The 'EBMT GVHD App' Improves the Accuracy of Graft-Versus-Host-Disease Assessment According to NIH Criteria Compared to Standard Practice BIOL BLOOD MARROW TR. 2016; 22(3):S284-S284.-BMT Tandem Meetings; FEB 18-22, 2016; Honolulu, HI.
(2016): THE HOMOZYGOUS TP53 P72R SNP IS ASSOCIATED WITH NON-FAVORABLE CYTOGENETIC RISK GROUPS IN ACUTE MYELOID LEUKEMIA HAEMATOLOGICA. 2016; 101: 383-383.
(2016): Three-Year Outcome After HSCT with Subsequent KT from the Same Haploidentical Donor without Immunosuppression. AM J TRANSPLANT. 2016; 16: 727-727.-American Transplant Congress; JUN 11-15, 2016; Boston, MA.
(2016): DNA methylation mapping and computational modeling in a large Ewing sarcoma cohort identifies principles of tumor heterogeneity and their impact on clinical phenotypes CANCER RES. 2016; 76: -AACR Special Conference on Advances in Pediatric Cancer Research - From Mechanisms and Models to Treatment and Survivorship; NOV 09-12, 2015; Fort Lauderdale, FL.
(2016): DOUBLE PROTEIN LYMPHOMA PATIENTS OF THE NON-GCB SUBTYPE HAVE AN INFERIOR PROGNOSIS WHEN TREATED WITH CHEMOIMMUNOTHERAPY. HAEMATOLOGICA. HAEMATOLOGICA101: 396-397. PAVIA: FERRATA STORTI FOUNDATION; ( Presented at: 21st Congress of the European-Hematology-Association, Copenhagen, DENMARK, JUN 09-12, 2016)
(2016): Identification of prognostic factors in patients with mature lymphoid malignancies undergoing autologous stem cell transplantation-a single center experience BONE MARROW TRANSPL. 2016; 51: S506-S506.-42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; APR 03-06, 2016; Valencia, SPAIN.
(2016): An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK.
(2016): A Higher Amount of More Primitive Stem Cells Is Mobilized By G-CSF Alone Compared to the Addition of Plerixafor: Autologous Blood Stem Cell Graft Composition Collected after Various Mobilization Methods BIOL BLOOD MARROW TR. 2016; 22(3):S137-S137.-BMT Tandem Meetings; FEB 18-22, 2016; Honolulu, HI.
(2016): Extracorporeal photopheresis in patients with steroid-refractory acute graft-versus-host disease: does the number of UVA-treated leukocytes impact response to therapy? BONE MARROW TRANSPL. 2016; 51: S375-S376.-42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; APR 03-06, 2016; Valencia, SPAIN.
(2016): TP53 germline mutations occur in acute myeloid leukemia and are associated with therapy-related cases following ionizing radiation WIEN KLIN WOCHENSCHR. 2016; 128: S385-S386.

2015 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2015): Anaphylaxis with clonal mast cells in normal looking skin - a new entity? Allergy. 2015; 70(7):864-872
(2015): 10th anniversary of the Austrian MDS Platform: aims and ongoing projects. Wien Klin Wochenschr. 2015; 127(1-2):12-15
(2015): Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia. Oncotarget. 2015; 6(5):3071-3084
(2015): Positive contrast of SPIO-labeled cells by off-resonant reconstruction of 3D radial half-echo bSSFP. NMR BIOMED. 2015; 28(1): 79-88.
(2015): Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test. Int J Antimicrob Agents. 2015; 46(4):401-405
(2015): Clinical-Pathological Conference Series from the Medical University of Graz Case No 155: 26-year-old woman in third trimester of pregnancy with epigastric pain and thrombocytopenia. Wien Klin Wochenschr. 2015; 127(17-18):707-714
(2015): Mutation Analysis of Nine Chordoma Specimens by Targeted Next-Generation Cancer Panel Sequencing. J Cancer. 2015; 6(10):984-989
(2015): Induction of the proapoptotic tumor suppressor gene Cell Adhesion Molecule 1 by chemotherapeutic agents is repressed in therapy resistant acute myeloid leukemia. Mol Carcinog. 2015; 54(12):1815-1819
(2015): Examination of survivin expression in 50 chordoma specimens--A histological and in vitro study. J Orthop Res. 2015; 33(5):771-778
(2015): Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study. BMC Infect Dis. 2015; 15(7):584-584
(2015): Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A. Haemophilia. 2015; 21(3):343-350
(2015): Placental mesenchymal stromal cells derived from blood vessels or avascular tissues: what is the better choice to support endothelial cell function? Stem Cells Dev. 2015; 24(1):115-131
(2015): Contaminated handwashing sinks as the source of a clonal outbreak of KPC-2-producing Klebsiella oxytoca on a hematology ward. Antimicrob Agents Chemother. 2015; 59(1):714-716
(2015): A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulin. Br J Haematol. 2015; 168(2):239-245
(2015): Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI. J Natl Compr Canc Netw. 2015; 13(12):1501-1508
(2015): Mitogen-Inducible Gene-6 Mediates Feedback Inhibition from Mutated BRAF towards the Epidermal Growth Factor Receptor and Thereby Limits Malignant Transformation. PLoS One. 2015; 10(6):e0129859-e0129859
(2015): A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies. Leukemia. 2015; 29(4):968-976
(2015): Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients. Mycoses. 2015; 58(8):461-469
(2015): Detection of central venous catheter-related bloodstream infections in haematooncological patients. Eur J Clin Invest. 2015; 45(8):824-832
(2015): Detection of (1→3)-β-D-glucan in same-day urine and serum samples obtained from patients with haematological malignancies. Mycoses. 2015; 58(7):394-398
(2015): MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients. Mol Carcinog. 2015; 54(11):1442-1450
(2015): Adipose triglyceride lipase acts on neutrophil lipid droplets to regulate substrate availability for lipid mediator synthesis. J Leukoc Biol. 2015; 98(5):837-850
(2015): Frequent down regulation of the tumor suppressor gene a20 in multiple myeloma. PLoS One. 2015; 10(4):e0123922-e0123922
(2015): miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients. Int J Mol Sci. 2015; 16(8):18077-18095
(2015): The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients. Eur J Haematol. 2015; 95(6):538-544
(2015): Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial. Ann Hematol. 2015; 94(4):593-601
(2015): Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues. Biol Blood Marrow Transplant. 2015; 21(12):2052-2060
Kurzbericht/Letter
(2015): Deletion of SPRY4 is a frequent event in secondary acute myeloid leukemia. Ann Hematol. 2015; 94(11):1923-1924
(2015): A gene expression profile associated with relapse of cytogenetically normal acute myeloid leukemia is enriched for leukemia stem cell genes. Leuk Lymphoma. 2015; 56(4):1126-1128
(2015): Preexisting TP53 mutation in therapy-related acute myeloid leukemia. Ann Hematol. 2015; 94(3):527-529
(2015): CyberKnife radiosurgery leading to long-lasting complete remission in locally relapsed solitary plasmacytoma of the bone. Ann Hematol. 2015; 94(7):1251-1253
(2015): Identification of a novel variant of epsilon-gamma-delta-beta thalassemia highlights limitations of next generation sequencing. Am J Hematol. 2015; 90(3): E52-E54.
Übersichtsarbeiten
(2015): Management of gastric mucosa-associated lymphoid tissue lymphoma. Dig Dis. 2015; 33(1):11-18
(2015): Molecular Pathogenesis of MALT Lymphoma. Gastroenterol Res Pract. 2015; 2015(9):102656-102656
(2015): The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms. Curr Drug Targets. 2015; 16(1):38-46

2015 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2015): Glykämie nach allogener Stammzelltransplantation bei Patienten mit akuter myeloischer Leukämie (AML) ist ein unabhängiger Prädiktor für das Überleben. Wiener Klinische Wochenschrift. 2015; 127(Suppl 4 ):S135-S135.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA.
(2015): Assoziation zwischen Hyperglykämie und ungünstigem Outcome bei Patienten mit akuter oder chronischer Graft-versus-Host Erkrankung (GvHD) nach allogener Stammzelltransplantation. Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S156-S157.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA.
(2015): Vascular aldosterone synthase contributes to phosphate-induced osteogenic transformation of vascular smooth muscle cells EUR HEART J. . 2015; 36: 439-439.-Congress of the European-Society-of-Cardiology (ESC); AUG 29-SEP 02, 2015; London, ENGLAND.
(2015): Efficacy of antibiotic prophylaxis in AML patients treated with low-intensity therapeutic regimens ONCOL RES TREAT. 2015; 38: 73-74.
(2015): Correlation between somatic comorbidities and anxiety and depression in patients after allogeneic hematopoietic stem cell transplantation ONCOL RES TREAT. 2015; 38: 148-148.
(2015): Allogeneic Stem Cell Transplantation In Patients With Acute Myeloid Leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR) CL LYMPH MYELOM LEUK. 2015; 15: S183-S183.
(2015): Influence of Platelet and White Blood Cell Counts until Major Thrombosis: Analysis from a Patient Registry in Essential Thrombocythemia BLOOD. 2015; 126(23):
(2015): NR4A1 AND NR4A3 POSSESS FUNCTIONAL REDUNDANCY BY REGULATING PRO-APOPTOTIC GENES IN AGGRESSIVE LYMPHOMAS. HAEMATOLOGICA. 2015; 100: 544-544.-20th Congress of European-Hematology-Association; JUN 11-14, 2015; Vienna, AUSTRIA.
(2015): NR4A3 Possesses Tumor Suppressive Properties like NR4A1 By Regulating Pro-Apoptotic Genes in Aggressive Lymphomas and Serves As a Potential Drug Target for Lymphoma Therapy BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
(2015): Allogeneic Hematopoietic Cell Transplantation (HCT) for Advanced Mycosis Fungoides and Sezary Syndrome (MF/SS): Impact of Increasing the Use of Unrelated Donors (UD) - the EBMT Lymphoma Working Party Experience BLOOD. 2015; 126(23):-55th Annual Meeting and Exposition of the American-Society-of-Hematology; DEC 07-10, 2013; New Orleans, LA.
(2015): Galactomannan Testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples obtained from patients with hematological malignancies at risk for invasive mould infection MYCOSES. 2015; 58: 157-157.-TIMM; OCT 9-13, 2015; Lissabon, Portugal.
(2015): Pregancy-associated thrombotic thrombocytopenic purpura in a 26-year old primipara MED KLIN-INTENSIVMED. 2015; 110(4):302-302.-47. Jahrestagung der DGIIN/ÖGIAIN; JUN 17-19, 2015; Koeln, GERMANY.
(2015): Acute and chronic GVHD: State of the art therapy ONCOL RES TREAT. 2015; 38: 114-114.
(2015): Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a ONCOL RES TREAT. 2015; 38: 99-99.
(2015): Allogeneic Stem Cell Transplantation for MDS Patients More Than 70 Years of Age: a Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT BLOOD. 2015; 126(23):-55th Annual Meeting and Exposition of the American-Society-of-Hematology; DEC 07-10, 2013; New Orleans, LA.
(2015): Development and Preliminary Usability and Accuracy Testing of the EBMT Gvhd App to Support Graft Versus Host Disease Diagnosis and Scoring According to NIH Criteria, By the EBMT Complications and Quality of Life Working Party BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
(2015): Prevalence of specific celiac disease of HLA Genotypes in Children and Adolescents with Type 1 Diabetes mellitus WIEN KLIN WOCHENSCHR. 2015; 127: S154-S154.
(2015): AGMT MALT-2: A Phase II Study of Rituximab Plus Lenalidomide in Patients with Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT lymphoma) BLOOD. 2015; 126(23):-55th Annual Meeting and Exposition of the American-Society-of-Hematology; DEC 07-10, 2013; New Orleans, LA.
(2015): CD19+CD21low B-cells as biomarker for the prediction and monitoring of response to immunosuppressive therapy for chronic graft-versus-host disease ONCOL RES TREAT. 2015; 38: 127-127.
(2015): Azacitidine in acute myeloid leukemia with >30% bone marrow blasts and &lt15 G/L white blood cell count: Results from the Austrian Azacitidine Registry of the AGMT Study Group versus randomized controlled phase III clinical trial data. Blood 2015. 2015; 126(23):-Annual Meeting of the American Society of Hematology; DEC 5-8, 2015; Orlando, USA.
(2015): Is it time to redefine response or treatment failure in elderly patients with WHO-AML unfit for intensive chemotherapy? Blood 2015. 2015; 126(23):-Annual meeting of the American Society of Hematology; DEC 5-8, 2015; Orlando, USA.
(2015): Typical STEMI - or not: embolic LAD occlusion and fulminant pulmonary embolism with in-transit thrombus in a patent foramen ovale EUR HEART J. 2015; 36: 1218-1219.-Congress of the European-Society-of-Cardiology (ESC); AUG 29-SEP 02, 2015; London, ENGLAND.
(2015): Calculation of the Galactomannan-Creatinine Index improves the Diagnostic Performance of Galactomannan testing from Urine Samples MYCOSES. 2015; 58: 110-110.
(2015): Diagnostic performance of 1,3-beta-d-glucan Serum Screening in Patients receiving Hematolopoietic Stem Cell Transplantation MYCOSES. 2015; 58: 159-159.
(2015): Bronchoalveolar Lavage 1,3-Beta-D-Glucan Testing for Prediction of Overall 30-day Mortality MYCOSES. 2015; 58: 110-110.
(2015): Role of allogeneic SCT in low risk MDS: A Retrospective Study on Behalf of the CMWP of the EBMT BONE MARROW TRANSPL. . 2015; 50: S109-S110.-41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; MAR 22-25, 2015; Istanbul, TURKEY.
(2015): C/EBP alpha-induced proinflammatory cytokines regulate early dendritic cell development ONCOL RES TREAT. 2015; 38: 249-250.
(2015): Low spinophilin expression is associated with poor prognosis and cellular growth in human breast cancer ANN ONCOL. IMPAKT Breast Cancer Conference. 2015; 26: -IMPAKT Breast Cancer Conference; MAY 07-09, 2015; Brussels, BELGIUM.
(2015): Steroid-induced hyperglycemia adversely impacts outcome in graft-versus-host disease ONCOL RES TREAT. 2015; 38: 129-129.
(2015): MiR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in aggressive non-Hodgkin's lymphoma patients ONCOL RES TREAT. 2015; 38: 63-64.
(2015): The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome BLOOD. 2015; 126(23):-55th Annual Meeting and Exposition of the American-Society-of-Hematology; DEC 07-10, 2013; New Orleans, LA.
(2015): Impact of linezolid on hematopoietic engraftment in patients after umbilical cord blood stem cell transplantation BONE MARROW TRANSPL. 2015; 50: S192-S192.-41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; MAR 22-25, 2015; Istanbul, TURKEY.
(2015): The zebra in the emergency department: a rare cause of acute dyspnoea and chest pain WIEN KLIN WOCHENSCHR. 2015; 127(19-20):822-823.
(2015): Loss of NR4A1 Accelerates the Development of Aggressive Lymphomas in Myc Induced Cancerogenesis BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.

2014 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2014): NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas. Blood. 2014; 123(15):2367-2377
(2014): Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force. Bone Marrow Transplant. 2014; 49(1): 49-54.
(2014): Serum and urine galactomannan testing for screening in patients with hematological malignancies. Med Mycol. 2014; 52(6):647-652
(2014): A comprehensive analysis of the cellular and EBV-specific microRNAome in primary CNS PTLD identifies different patterns among EBV-associated tumors. Am J Transplant. 2014; 14(11):2577-2587
(2014): Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies. Int J Antimicrob Agents. 2014; 44(2):140-144
(2014): Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2014; 52(6):2039-2045
(2014): Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial. Ann Hematol. 2014; 93(3):459-462
(2014): Mesenchymal stromal cells from the human placenta promote neovascularization in a mouse model in vivo. Placenta. 2014; 35(7):517-519
(2014): Early remodeling of perinuclear Ca2+ stores and nucleoplasmic Ca2+ signaling during the development of hypertrophy and heart failure. Circulation. 2014; 130(3):244-255
(2014): Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma. Blood. 2014; 123(7):985-991
(2014): R-CHOP versus R-COMP: are they really equally effective? Clin Oncol (R Coll Radiol). 2014; 26(10):648-652
(2014): Effects of directly autotransplanted tibial bone marrow aspirates on bone regeneration and osseointegration of dental implants. Clin Oral Implants Res. 2014; 25(4):468-474
(2014): Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group. Ann Hematol. 2014; 93(11):1825-1838
(2014): Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer. Oncotarget. 2014; 5(18):8492-8502
(2014): Assessment of the response to acetylsalicylic acid in patients with myeloproliferative neoplasms by whole blood assays: a comparison of the PFA-100 with multiple electrode aggregometry. Platelets. 2014; 25(8):608-611
(2014): The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma. Br J Cancer. 2014; 110(2):369-374
(2014): C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients. Br J Cancer. 2014; 111(1):55-60
(2014): Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation. Br J Haematol. 2014; 166(5):749-757
(2014): Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2014; 49(7):887-894
(2014): Safety and tolerability of intrathecal liposomal cytarabine as central nervous system prophylaxis in patients with acute lymphoblastic leukemia. Leuk Lymphoma. 2014; 55(8):1739-1742
(2014): Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F. Arch Pathol Lab Med. 2014; 138(9):1203-1209
Übersichtsarbeiten
(2014): MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer. World J Gastroenterol. 2014; 20(33):11727-11735
(2014): MicroRNAs in diffuse large B-cell lymphoma: implications for pathogenesis, diagnosis, prognosis and therapy. Anticancer Res. 2014; 34(2):557-564
Kommentare
(2014): Novel face of microRNA-155. Blood. 2014; 123(1):5-7

2014 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2014): Allogeneic Stem Cell Transplantation in patients with acute myeloid leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR) ONCOL RES TREAT. 2014; 37: 134-134.
(2014): Leukocyte Count Defines Patients on Risk for Thrombotic Complications with Well Controlled Essential Thrombocythemia-Data from a Patient- Registry BLOOD. 2014; 124(21):
(2014): NR4A3-MEDIATED APOPTOSIS SUPPRESSES LYMPHOMAGENESIS IN A XENOGRAFT MOUSE MODEL HAEMATOLOGICA. .. 2014; 99: 136-136.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
(2014): Comparision of Mannan/Anti-Mannan and 1,3-beta-D-Glucan Screening for Invasive Candida Infection in Patients with Hematologic Malignancies MYCOSES. 2014; 57: 33-34.
(2014): Serum and Urine Galactomannan testing for screening in patients with hematological malignancies MYCOSES. 2014; 57: 24-24.
(2014): Autologous Stem Cell Transplantation with Benda-BEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) in Aggressive Non Hodgkin and Hodgkin's Lymphoma BLOOD. 2014; 124(21):
(2014): Base Excision Repair Glycosylase Activity Is Impaired in a Subgroup of Acute Myeloid Leukemia Resulting in Increased Levels of Oxidative Base Lesions BLOOD. 2014; 124(21):-56th Annual Meeting of the American-Society-of-Hematology; DEC 06-09, 2014; San Francisco, CA.
(2014): Base excision repair glycosylase activity is impaired in a subgroup of acute myeloid leukemia resulting in increased levels of oxidative base lesions Oncol Res Treat. 2014; 37(S5):49-49.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14; Hamburg, GERMANY. (ISBN: 978-3-318-02811-9 )
(2014): Diagnostics for invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid of Patients with Underlying Pulmonary Diseases: Comparison of Aspergillus Lateral Flow Device, Galactomannan-Antigen-Test, Beta-D-Glucan-Tests and Conventional Culture MYCOSES. 2014; 57: 15-16.
(2014): A PHASE II STUDY OF RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF THE MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT LYMPHOMA) HAEMATOLOGICA. . 2014; 99: 226-226.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
(2014): Bronchoalveolar Lavage Lateral-Flow Device Test for Diagnosing Invasive Pulmonary Aspergillosis in ICU and Haematological patients MYCOSES. 2014; 57: 34-34.
(2014): EFFECTS OF THE PI3-KINASE/MTOR INHIBITOR BEZ235 ON ONCOGENIC SIGNALING, PROLIFERATION AND SURVIVAL OF LEUKEMIC CELLS IN CML HAEMATOLOGICA. 2014; 99: 67-67.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
(2014): The PI3K/mTOR blocker BEZ235 and BCR/ABL TKIs exert synergistic growth-inhibitory effects in CML cells ONCOL RES TREAT. 2014; 37: 56-56.
(2014): Mutation analysis of nine chordoma specimens by targeted next generation cancer panel sequencing VIRCHOWS ARCH. 2014; 465: S326-S326.
(2014): UPDATED REPORT OF THE AUSTRIAN CML REGISTRY HAEMATOLOGICA. 2014; 99: 341-341.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
(2014): SELECTION OF A PRE-EXISTING TP53 MUTATED CLONE IN THERAPY-RELATED ACUTE MYELOID LEUKEMIA Haematologica. 2014; 99(S1):15-15.-19th Congress of the European Hematology Association; JUNE 12-15, 2014; Milan, ITALY.
(2014): Germline variants in the semaphorin SEMA4A confer susceptibility to familial colorectal cancer type X Oncol Res Treat. 2014; 37(S5):105-105.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14, 2014; Hamburg, GERMANY. (ISBN: 978-3-318-02811-9 )
(2014): Effects of single-Agent Bortezomib as posttransplant Consolidation on Multiple Myeloma-related Bone Didease; First Results from a Multicenter,randomized Phase 2 Study Haematologica. 2014; 99(S1):362-362.-19th Congress of the European Hematology Association; June 12-15, 2014; Milan, ITALY.
(2014): HIGH EXPRESSION OF MIRNA-199A_1 AND MIRNA-497_1 IS ASSOCIATED WITH BETTER OVERALL SURVIVAL IN AGGRESSIVE NON-HODGKIN'S LYMPHOMA HAEMATOLOGICA. 2014; 99: 135-135.
(2014): Distinct chemokine receptor profiles in Richter's transformation compared to de-novo diffuse large B-cell lymphoma and germinal center B-cells ONCOL RES TREAT. 2014; 37: 72-73.
(2014): ANALYSES OF NUCLEAR ORPHAN RECEPTOR EXPRESSION AND CYTOTOXICITY FOLLOWING ANTI-CD 20 MONOCLONAL ANTIBODY TREATMENT IN AGGRESSIVE NON-HODGKIN'S LYMPHOMAS HAEMATOLOGICA. 2014; 99: 685-686.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
(2014): Patients with aggressive B-cell lymphomas display distinct chemokine receptor profile and an association of low CCR7 expression and favorable cancer specific survival ONCOL RES TREAT. 2014; 37: 73-73.
(2014): A role of C/EBP-Alpha in Development of Plasmacytoid Dendritic Cells in the Thymus Haematologica. 2014; 99(S1):174-174.-19th Congress of European Hematology Association; JUN 12-15, 2014; Milan, ITALY.
(2014): RAF kinase inhibitor protein is involved in the regulation of myelomonocytic differentiation. Oncol Res Treat. 2014; 37(S5):49-49. 2014; 37(S5):24-24.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14; Hamburg. (ISBN: 978-3-318-0281 )

2013 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2013): Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma. Mod Pathol. 2013; 26(2):182-194
(2013): Primary antiphospholipid antibody syndrome-one further aspect of thrombophilia in overweight and obese patients with venous thromboembolism. Obesity (Silver Spring). 2013; 21(9):E463-E466
(2013): Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies. Antimicrob Agents Chemother. 2013; 57(7):3262-3267
(2013): Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy. Mycoses. 2013; 56(4):471-476
(2013): Which lumen is the source of catheter-related bloodstream infection in patients with multi-lumen central venous catheters? Infection. 2013; 41(1):49-52
(2013): Tri-lineage potential of intraoral tissue-derived mesenchymal stromal cells. J Craniomaxillofac Surg. 2013; 41(2):110-118
(2013): Azacitidine in patients with WHO-defined AML - results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group. J Hematol Oncol. 2013; 6(4):32-32
(2013): Identification of an effective early signaling signature during neo-vasculogenesis in vivo by ex vivo proteomic profiling. PLoS One. 2013; 8(6):e66909-e66909
(2013): 90Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical Trial. J Clin Oncol. 2013; 31(3):308-313
(2013): Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles. EUR J PHARM BIOPHARM. 2013; 85(3 Pt A): 346-355.
(2013): Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie. Haematologica. 2013; 98(2):264-268
(2013): Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasm. Bone Marrow Transplant. 2013; 48(6):799-802
(2013): Microbiological screening for earlier detection of central venous catheter-related bloodstream infections. Eur J Clin Invest. 2013; 43(9):964-969
(2013): α/β-hydrolase domain containing protein 15 (ABHD15)--an adipogenic protein protecting from apoptosis. PLoS One. 2013; 8(11):e79134-e79134
(2013): A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies. J Craniomaxillofac Surg. 2013; 41(2):153-161
(2013): C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence. Nat Cell Biol. 2013; 15(4):385-394
Kurzbericht/Letter
(2013): Molecular Cytogenetics and Multiplex Reverse-Transcriptase Polymerase Chain Reaction for Risk Stratification in Acute Myeloid Leukemia. J Clin Oncol. 2013; 31(18):2360-2361
(2013): Mutant DNMT3A in acute myeloid leukemia: guilty of inducing genetic instability? Leukemia. 2013; 27(8): 1777-1778.
Kommentare
(2013): Early and late posttransplant lymphoproliferative disorder after lung transplantation--34 cases from the European PTLD Network. Transplantation. 2013; 96(3):e18-e19

2013 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2013): Allogeneic stem cell transplantation in patients with acute myeloid leukaemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR). BONE MARROW TRANSPLANT. BONE MARROW TRANSPLANTATION48: S393-S393. LONDON: NATURE PUBLISHING GROUP; ( Presented at: 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, ENGLAND, APR 07-10, 2013)
(2013): The tyrosine kinase inhibitor (TKI) imatinib produces mast cell deficiency in Ph plus chronic myeloid leukemia ONKOLOGIE. 2013; 36: 63-63.
(2013): Phenotype and Target Expression Profiles of Leukemic Stem Cells in Ph plus and Ph- Acute Lymphoblastic Leukemia (ALL) ONKOLOGIE. . 2013; 36: 182-183.
(2013): Impact of structured on-site patient education on low posaconazole plasma concentrations. MYCOSES. 2013; 56: 47-47.-6th Trends in Medical Mycology; OCT 11-14, 2013; Kopenhagen, DENMARK.
(2013): Bronchoalveolar lavage lateral-flow device test for diagnosing invasive pulmonary aspergillosis: a multicenter study. MYCOSES. 2013; 56: 71-71.-6th Trends in Medical Mycology; OCT 11-14, 2013; Kopenhagen, DENMARK.
(2013): Comparision of galactomannan and beta-D-glucan serum assays for diagnosis of invasive fungal infections in hematologic malignancy patients. MYCOSES. 2013; 56: 71-72.-6th Trends in Medical Mycology; OCT 11-14, 2014; Kopenhagen, DENMARK.
(2013): Serum and urine galactomannan testing for screening in patients with hematological malignancies. MYCOSES. 2013; 56: 85-85.-6th Trends in Medical Mycology; OCT 11-14, 2013; Kopenhagen, DENMARK.
(2013): Parameters influencing factor VIII half-life and recovery in patients with haemophilia A J THROMB HAEMOST. .. 2013; 11: 356-356.
(2013): Screening for early pulmonary vascular changes in patients with chronic myeloproliferative disorders ONKOLOGIE. 2013; 36: 64-64.
(2013): In vitro effects of dimethylacrylshikonin on melanoma cells J DTSCH DERMATOL GES. . 2013; 11: 92-92.
(2013): Graft versus Host Disease ONKOLOGIE. 2013; 36: 24-24.
(2013): UCBT with low-dose ATG in adult patients ONKOLOGIE. 2013; 36: 127-128.
(2013): Autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) in aggressive NHL and Hodgkin Lymphoma ONKOLOGIE. 2013; 36: 7-7.-Jahrestagung der Österr. ,Deutschen und Schweizer Gesellschaften für Hämatologie und OnkologieOKT; OKT 15-16, 2013; Wien, Austria.
(2013): The prevalence of erythroblasts in peripheral blood smears of patients with multiple sclerosis treated with natalizumab ONKOLOGIE. . 2013; 36: 207-207.
(2013): Natalizumab induces erythroblastaemia in the majority of treated patients MULT SCLER J. . 2013; 19(11):278-278.-29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS; OCT 02-05, 2013; Copenhagen, DENMARK.
(2013): Progression of light chain myeloma to secondary plasma cell leukemia associated with peripheral blood eosinophilia ONKOLOGIE. 2013; 36: 156-156.
(2013): Changes in platelet function and response to antiaggregatory treatment in patients with myeloproliferative neoplasms: A sequential study using multiple electrode aggregometry ONKOLOGIE. . 2013; 36: 63-64.
(2013): Updated report of the Austrian CML registry ONKOLOGIE. 2013; 36: 63-63.-Jahrestagung der Österr., Deutschen und Schweizer Gesellschaften für Hämatologie und Onkolofie; OKT 15-16, 2013; Wien, Austria.
(2013): Risk factors and outcomes after umbilical cord blood transplant for adults with Philadelphia positive acute lymphoblastic leukaemia and impact of minimal residual disease before transplant. BONE MARROW TRANSPLANT. BONE MARROW TRANSPLANTATION48: S42-S42. LONDON: NATURE PUBLISHING GROUP; ( Presented at: 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, ENGLAND, APR 07-10, 2013)
(2013): Distinct Chemokine Receptor Profile In Chronic Lymphocytic Leukaemia and Richter Transformed Diffuse Large B Cell Lymphomas Compared To Germinal Center B Cells and De Novo Diffuse Large B Cell Lymphomas. BLOOD. BLOOD122: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 55th Annual Meeting of the American-Society-of-Hematology, New Orleans, LA, DEC 07-10, 2013)

2012 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2012): Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation. Pediatr Transplant. 2012; 16(2):131-136
(2012): Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment. Blood. 2012; 119(21):4971-4980
(2012): The nuclear orphan receptors NR4A as therapeutic target in cancer therapy. Anticancer Agents Med Chem. 2012; 12(9):1001-1014
(2012): Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial. Biol Blood Marrow Transplant. 2012; 18(11):1716-1726
(2012): Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia. Haematologica. 2012; 97(2):246-250
(2012): Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies. Int J Antimicrob Agents. 2012; 39(6):510-513
(2012): Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies. Med Mycol. 2012; 50(3):266-269
(2012): European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies. J Antimicrob Chemother. 2012; 67(8):2029-2033
(2012): Oxygen sensing mesenchymal progenitors promote neo-vasculogenesis in a humanized mouse model in vivo. PLoS One. 2012; 7(9):e44468-e44468
(2012): Endothelial colony-forming progenitor cell isolation and expansion. Methods Mol Biol. 2012; 879(4):381-387
(2012): Naphthoquinones from Onosma paniculata induce cell-cycle arrest and apoptosis in melanoma Cells. J Nat Prod. 2012; 75(5):865-869
(2012): Human intraoral harvested mesenchymal stem cells: characterization, multilineage differentiation analysis, and 3-dimensional migration of natural bone mineral and tricalcium phosphate scaffolds. J Oral Maxillofac Surg. 2012; 70(10):2309-2315
(2012): Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (GHO) Wien Klin Wochenschr. 2012; 124(3-4):111-123
(2012): What are a patient's current chances of finding a matched unrelated donor? Twenty years' central search experience in a small country. Bone Marrow Transplant. 2012; 47(2):172-180
(2012): Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases. Onkologie. 2012; 35(7-8):447-450
(2012): Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms. J Med Genet. 2012; 49(7):422-428
(2012): Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression. Circulation. 2012; 126(4):430-439
(2012): Human dermis harbors distinct mesenchymal stromal cell subsets. J Invest Dermatol. 2012; 132(3 Pt 1):563-574
(2012): Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: Open questions. Crit Rev Oncol Hematol. 2012; 82(3):370-377
Kurzbericht/Letter
(2012): Mutations inDNMT3A and loss of RKIP are independent events in acute monocytic leukemia. Haematologica. 2012; 97(12):1936-1937
(2012): Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients. J Infect. 2012; 65(6): 588-591.
(2012): Hypersensitivity to alkylation treatment of primary fibroblasts from patients with therapy-related myeloid neoplasms. Leuk Res. 2012; 36(7):e137-e139
(2012): Upfront radioimmunotherapy represents an effective and safe therapeutic option in cutaneous B-cell non-Hodgkin lymphoma. Ann Hematol. 2012; 91(1): 129-130.
(2012): Disseminated Geosmithia argillacea infection in a patient with gastrointestinal GvHD. Bone Marrow Transplant. 2012; 47(5): 734-736.
Übersichtsarbeiten
(2012): Clinical potential of VIP by modified pharmaco-kinetics and delivery mechanisms. Endocr Metab Immune Disord Drug Targets. 2012; 12(4):344-350

2012 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2012): POTENTIAL ROLE OF NUCLEAR ORPHAN RECEPTORS NR4A1 AND NR4A3 IN HUMAN CHONDROCYTES OSTEOARTHR CARTILAGE. 2012; 20: S140-S140.-World Congress on Osteoarthritis; APR 26-29, 2012; Barcelona, SPAIN.
(2012): Xeno-free culturing of human muscle precursor cells (MPC) for clinical application. 3rd Annual TERMIS World Congress: Tissue Engineering and Regenerative Medicine. 2012; 6(suppl1):132-132.-DGTI; SEP 5-8, 2012; Vienna, AUSTRIA.
(2012): Reduction of NR4A1 is associated with poor survival aggressive lymphomas. ONKOLOGIE. 2012; 35: 104-104.-Gemeinsame Jahrestagung 2012 der DGHO, ÖGHO, SGMO und SGH+SSH ; Okt 19-23, 2012; Stuttgart.
(2012): NR4A1 Mediated Apoptosis of Aggressive Lymphoma Cells Suppresses Tumor Growth in a Xenograft Model. BLOOD. . 2012; 120(21):-54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 08-11, 2012; Atlanta, GA.
(2012): Platelet-derived factors preserve human mesenchymal cell stemness and promote endochondral bone and marrow niche formation via PDGF-receptor signalling BONE MARROW TRANSPL. 2012; 47: S49-S50.
(2012): Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival THROMB RES. 2012; 129: S181-S181.-6th International Conference on Thrombosis and Hemostasis Issues in Cancer; APR 20-22, 2012; Bergamo, ITALY.
(2012): Collagen receptor-mediated mechanochemical signalling modulates human pro-angiogenic mesenchymal stem/progenitor cells during neovascularisation BONE MARROW TRANSPL. 2012; 47: S317-S317.
(2012): Collagen Receptor-Mediated Mechanochemical Signaling Contributes to Human Pro-Angiogenic Mesenchymal Stem/Progenitor Cell-Induced Neo-Vasculogenesis. BLOOD. . 2012; 120(21):-54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 08-11, 2012; Atlanta, GA.
(2012): Host factors for invasive fungal infection among patients with hematological malignancies MYCOSES. 2012; 55: 249-249.-18th Congress of the International Society for Human and Animal Mycology 2012 (ISHAM 2012); JUN 11-15, 2012; Berlin, GERMANY.
(2012): Therapeutic neo-vasculogenesis in vivo is promoted by oxygen sensing mesenchymal stem/progenitor cells BONE MARROW TRANSPL. 2012; 47: S319-S320.
(2012): Autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) in aggressive NHL and Hodgkin Lymphoma. ONKOLOGIE. 2012; 35: 42-42.-Gemeinsame Jahrestagung der Deutschen, Österr. Und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 19.23 ,2012; Stuttgart.
(2012): Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated. BLOOD. . 2012; 120(21):-54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 08-11, 2012; Atlanta, GA.
(2012): Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated. BLOOD. BLOOD120: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, DEC 08-11, 2012)
(2012): Organotypic Epigenetic Signature Predicts Bone and Marrow Niche Forming Capacity of Stromal Progenitors in a Novel Mouse Model in Vivo. BLOOD. BLOOD120: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, DEC 08-11, 2012)
(2012): Bone and haematopoietic niche formation is predetermined by a specific epigenetic signature BONE MARROW TRANSPL. 2012; 47: S48-S49.
(2012): Early in vivo signalling signature during human stem/progenitor cell-derived neo-vasculogenesis BONE MARROW TRANSPL. 2012; 47: S49-S49.
(2012): Maintenance of Osteogenic Differentiation Capacity of MSPC Despite Amplified Proliferation Under Elevated Oxgen Conditions. BLOOD. BLOOD120: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, DEC 08-11, 2012)
(2012): Elevated oxygen environment boosts MSPC proliferation without senescence aggravation BONE MARROW TRANSPL. 2012; 47: S319-S319.
(2012): Germ-line mutations in cancer predisposing genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy-related myeloid neoplasms. ONKOLOGIE. Onkologie. 2012; 35: 117-117.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 19-23, 2012; Stuttgart, GERMANY.
(2012): Update from the myeloma registry of the University Hospital Graz - impact of new drugs on disease management in the transplant setting. ONKOLOGIE. 2012; 35: 146-146.-Jahrestagung der DÖGHO; OKT 19-23. 2012; Stuttgart.
(2012): Evaluating immunogenicity of human endothelial colony forming cells for application in cell-based therapies. 3rd Annual TERMIS Congress: Tissue Engineering and Regenerative Medicine. 2012; 6(suppl1):247-247.-TERMIS; SEP 5-8, 2012; Vienna, AUSTRIA.
(2012): Rituximab plus subcutaneous Cladribine in patients with extranodal marginal zone B-cell Lymphoma of the Mucosa associated tissue (MALT-Lymphoma): A Phase II study by the AGMT Annals of Oncology. 2012; 23(9):352-352.-37th ESMO Congress; SEP 28-OCT 2, 2012; VIENNA, AUSTRIA. (ISBN: 1569-8041 )
(2012): Unrelated stem cell transplantation induces long term disease control in patients with blastic plasmocytoid dendritic cell neoplasm. ONKOLOGIE. 2012; 35: 212-213.-Jahrestagung der DÖGHO; OKT 19-23. 2012; Stuttgart.